Home Contact Center Add this

11 January 2017 / international

GenePOC to Announce CE Marking of its revogene™ Instrument and its Second Test, CDiff [Read more]

10 January 2017 / international

Debiopharm International SA Announces positive Phase 2 Clinical Trial with Debio 1450 in ABSSSI patients [Read more]

09 January 2017 / International

Debiopharm Group’s Triptorelin 6-month Formulation Receives Approval for the Treatment of Central Precocious Puberty (CPP) in Europe [Read more]

ALL NEWS

09 January 2017

Debiopharm Group’s Triptorelin 6-month Formulation Receives Approval for the Treatment of Central Precocious Puberty (CPP) in Europe [Read more]

02 June 2016

FDA grants Orphan Drug Designation to Debiopharm International SA’s IAP inhibitor Debio 1143 in the treatment of ovarian cancer [Read more]

15 April 2016

Debiopharm International SA announces presentation at AACR of non-clinical data relating to its targeted investigational compound Debio 1347/CH5183284, a selective FGFR 1,2,3 inhibitor [Read more]

ALL NEWS

18 December 2014

Debiopharm Investment, Ardian, Nixdorf Foundation and Bernis today acquire Eco Delta solar activities [Read more]

27 November 2014

Debiopharm Investment becomes a minority shareholder in Haut-Lac International Bilingual School in St-Légier (VD) [Read more]

17 November 2014

Coorpacademy, établi à l’EPFL et l’un des leaders des MOOCs à destination des entreprises, lève 3,2 millions d’euros auprès de Debiopharm Investment et du fonds français NextStage [Read more]

ALL NEWS

01 December 2016

Chemosensitization to Carboplatin and Paclitaxel by IAP Inhibitor Debio 1143 in Ovarian Cancer Cell Lines: Signature Identification for Potential Patient Stratification [Read more]

29 October 2016

Paclitaxel-Carboplatin With The Oral Iap Inhibitor Debio1143 In A Subset Of Patients With Recurrent Epithelial Ovarian Cancer (EOC): Phase I [Read more]

29 October 2016

The Staphylococcal-specific Antibiotic Debio 1450 Minimizes Disturbance to the Gut Microbiota in Mice [Read more]

ALL NEWS

bulle slideshow group

bulle slideshow diagnostics

bulle slideshow international

bulle slideshow investment

bulle slideshow research